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Abstract. Due to the fact that pyodermas are wide spread and sometimes hard to diagnose and control, 
updating the data found in the scientific literature allows correct identification of the causes which are 
at the base of the occurrence of the infectious process and implementation of an efficient therapeutic 
management, making prevention possible. In order to diagnose and obtain optimal results, the 
following must be done: a complete medical history, a detailed clinical exam, cutaneous cytology 
exams, antibiogram bacteriologic exam, and, if necessary, a histopathological exam. Staphylococcus 
pseudintermedius is the etiological agent involved in the majority of pyoderma cases.  Recent studies 
have shown that, although pyodermas are classified as primary and secondary, depending on the 
generation process, secondary pyodermas have a higher occurrence rate in practice. Primary 
pyodermas are considered to be idiopathic. Therefore, treating the primary conditions which cause 
their occurrence, represents the guarantee in avoiding a relapse.  Literature data claim that pyoderma 
treatment is done according to the depth of the infectious process, using an exclusively local treatment 
or a combined one: systemic and topical. In the worst cases, the auto vaccine represents a solution 
against relapses.  The knowledge of the pathogenetic process, of the clinical panel and the importance 
of using specific complementary exams, allow a therapeutic approach which is appropriate to the 
infectious process, as well as treatment cost reduction.  
 
INTRODUCTION 
 
Pyoderma is the most widespread bacterial disease found in dogs. Being one of the 
conditions with a great lesional diversity, the best knowledge of the pathogenic process and 
the clinical panel allows an efficient therapeutic approach, thus cutting the costs of diagnosis 
and treatment. An incomplete or inappropriate approach of the treatment sometimes leads to 
complications in the pathological process, which prolongs the evolution of the disease and 
favorizes the occurrence of unwanted consequences for the animal as well as for the owner, 
thus becoming a constant source of displeasure for the doctor also. This is why we consider 
that updating the knowledge in this field that exists up to this moment, worldwide, comes in 
help for the DVM.   Throughout time, based on an accumulation of practical and literature 
data, a pyoderma classification was tried, around a number of criteria: the morphology and 
topography of the cutaneous lesions, etiologic agent etc.  
Based on the depth of the lesions, the extension of the infectious process, the animals’ 
age and the developing mechanism, pyoderma can be: superficial or deep, localized or 
generalized, specific to young or old animals, primary or secondary.  A special category is 
represented by pseudopyoderma, which are wrongfully considered pyoderma, because of the 
partial understanding of the pathogenic process. These are surface bacterial colonizations or 
over-infected conditions. The pathogen or conditioned pathogen microorganisms multiply at 
the level of the primary lesions. In the consulted literature (2, 6, 11, 12, 13), concerning the 
classification of the cutaneous conditions in dogs, there are still different points of view when 
it comes to naming certain conditions. I believe that out of all the existing classifications, the 
closest to reality is the one that uses the anatomo-clinical criterion and is based on the 
profoundness and distribution of the infectious process across the affected animal’s body.  
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PATHOGENESIS 
 
The skin’s physical protection is ensured by the hair, cutaneous microclimate (in 
which saprophite bacteria hold an important role, the skin’s temperature, humidity and pH) 
and the permanent scaling of the stratum corneum which prevents contact between the skin 
and pathogens, as well as their entrance and growth.The chemical protection is provided by 
the cutaneous secretions of the sebaceous and  sweat glands 
The immunological protection is ensured by: nonspecific immunity, provided by 
polymorphonuclear cells, macrophages and the complement system; specific immunity, 
through the cutaneous immune system: keratynocites, Langerhans cells, dendrocytes, 
lymphocytes, mastocytes, which determines the activation of the humoral immune system (B 
lymphocytes: antibodies) and the cellular immune system (neutrophils, macrophages) 
Bacterias are normally found on the dog’s skin, such as: staphylococcus coagulase 
negative (S. epidermicus, S.xylosus), micrococcus, Gram positive bacilli like corynebacterium 
and Gram negative bacilli like Acinetobacter (Muller, 1983). In dogs, Staphylococcus 
pseudintermedius( 8, 9) is part of the normal skin flora, being a resident of the mucosas (10). In 
certain favorable conditions like improper coat maintenance, nutrition deficiencies, poor 
hygiene, morphological characteristics of certain breeds (excessive cutaneous folds), preexistent 
dermatoses (parasitic, allergies, dysendocrinias, keratinization disorders, immunodeficiencies, 
poor anterior treatments (antibiotherapy for a short period of time, underdosed, the use of an 
inappropiate antibiotic) or not recommended – with glucocorticoids), the staphylococci break 
the cutaneous ecosystem’s equilibrium, become pathogenic and can determine serious 
pyoderma. Secondary to the growth of pathogenic staphylococci, other bacterias can occur, 
especially Gram negative like Pseudomonas, Proteus, Echerichia (Muller et al. 1983). 
Staphylococcus pseudintermedius, along with Staphylococcus intermedius and 
Staphylococcus delphini, is part of  the Staphylococcus intermedius group (SIG), and it is the 
main pathogenic species involved in a great variety of infections in dogs and other species, 
including humans (Devriese et al. 2005; 2009).  Hermans (quoted by de Bond and Loeffler, 
2012) proposed in 2010 that „every staphylococcus isolated in dogs, that posseses the 
phenotypic characteristics of Staphylococcus intermedius is to be considered as part of the 
Staphylococcus pseudintermedius species.”  Many authors (2,4,6,11,12) consider that 
pyodermas are almost exclusively secondary disorders, due to their overlapping occurence on a 
series of primary conditions which develop on a cutanoeus level (they affect the skin barrier, 
favorizing the pathogenic bacterial growth). It must be mentioned that some staphylococci 
strains synthesize certain types of ensymes and toxins during their growth, which complicate 
the preexistent lesions, accelerating the bacterial growth even more, as well as the aggravation 
of lesions. In Staphylococcus spp. induced pyodermas, the infectious process is developed in 
the presence of skin homeostasis affecting conditions and allow staphylococci to manifest 
their pathogenicity, thus neutralizing the host's defense mechanisms. 
Staphylococci (S. pseudintermedius in 90% of cases, but sometimes S. aureus, S. 
hyicus and S. schleiferi) multiply excessively and easily adhere (due to surface proteins) to the 
keratinocytes of the stratum corneum, invading hair follicles and sweat glands, where they 
proliferate due to invasive enzymes, affecting tissues and causing disease symptoms. 
Due to factors of toxicity such as exotoxins like cytotoxic hemolysins and toxins, the 
targeted cell membranes are disrupted (exfoliative toxin responsible for scalded skin 
syndrome in children, leukocydins, toxin A synthesized under the action of a gene in the 
bacterial chromosome and toxin B determined by a gene in plasmid DNA). Other pathogenic 
factors expressed by staphylococci are: surface factors that inhibit phagocytosis, like protein 
A which binds immunoglobulins, inactivating them, while acting as a superantigen causing 
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hypersensitivity reactions and facilitating further penetration of toxins and the polysaccharide 
capsule which helps to disguise the antigen; extracellular enzymes, such as phosphatase, 
nuclease, hyaluronidase, etc. that help the emergence of resistance. The clinico-lesional panel 
is different, sometimes characteristic to each morbid entity. Due to the fact that pyoderma 
have a clinical manifestation consistent to a large array of lesions, it represents one of the 
most encountered and controversial dermatological conditions found in dogs.   
The main lesional aspects found in dog pyoderma are exposed comparatively in tab 1. 
The diagnosis is established based on a thorough anamnesis, cytological examination, 
bacteriological examination and sometimes based on a histopathological examination. Cocci 
and / or bacilli, images proliferation, bacterial colonization and invasion can be identified on a 
cytological examination. (1, 2, 6, 7, 11). In the image regarding bacterial colonization 
numerous extracellular cocci and / or bacilli can be seen, as well as numerous healthy 
neutrophils, degenerate PNN (some in the phagocytic phase, phenomenon represented by the 
presence of a vacuole with bacteria within PNN). In case of bacterial invasion an important 
number of degenerate polynuclear neutrophils, sometimes macrophages, are seen. Cocci and / 
or bacilli are present in a greater or smaller number outside the cell and rarely intracellular. 
 
Tabel 2 
Systemic antibiotics 
 
GROUP ANTIBIOTICS DOSES 
MACROLIDES 
AND 
LINCOSAMIDE 
Erythromycin 30 – 50 mg/kg divided in 2-3 doses per day 
Lincomicyn 40 – 50 mg/kg, divided in 2-3 doses per day 
Clindamicyn 11 mg/kg /day 
 
SEMISYNTHETIC 
PENICILLIN 
Amoxicillin with clavulanic acid 12,5 mg/kg  BID 
Oxaciclyn (resistant to 
staphylococcal penicillinase) 
15 – 30 mg/kg BID 
CEPHALOSPORINS 
Cephalexin 15 – 35 mg/kg BID / 15 – 30 mg/kg BID 
Cefadroxil 22 – 35 mg/kg BID 
Cofovecin 8 mg/kg la 14 zile subcutanat 
SULFAMIDS 
POTENTIATED BY 
DIAMINO-PIRIMIDINS 
Trimethoprim-sulfadiazinE/ 
sulfa-metoxazol 
5mg/kg of trimethoprim,  
once or twice daily 
FLUOROQUINOLONS 
(AND-girase inhibitors) 
Enrofloxacin 5 mg/kg once daily or divided in 2 doses/day 
Marbofloxacin 2 mg/kg, once daily 
Difloxacin 5 mg/kg once daily 
Orbifloxacin 2,5 mg/kg once daily 
Pradofloxacin 3 mg/kg once daily 
PEPTOLIDS Rifampicin 5 - 10 mg/kg /day 
 
The diagnosis is established based on a thorough anamnesis, cytological examination, 
bacteriological examination and sometimes based on a histopathological examination. Cocci 
and / or bacilli, images proliferation, bacterial colonization and invasion can be identified on a 
cytological examination. (1, 2, 6, 7, 11). In the image regarding bacterial colonization 
numerous extracellular cocci and / or bacilli can be seen, as well as numerous healthy 
neutrophils, degenerate PMN (some in the phagocytic phase, phenomenon represented by the 
presence of a vacuole with bacteria within PMN). In case of bacterial invasion an important 
number of degenerate polynuclear neutrophils, sometimes macrophages, are seen. Cocci and / 
or bacilli are present in a greater or smaller number outside the cell and rarely intracellular. 
A bacterial culture and antibiogram allow isolation and identification of bacterial 
species, certain pathogenic characteristics and indicate what antibiotic should be used.  
Those exams are absolutely necessary in  a  number of situations: in case of a difficult 
differential diagnosis, if bacilli are seen on cytological examinations, in case of deep 
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pyoderma, in case of chronic or recurrent superficial pyoderma and if the antibiotic 
treatment failed. Because contamination with methicillin-resistant staphylococci has 
become a commonplace reality of our time and due to the fact that several bacterial species 
may be involved in deep lesions, it is recommended to perform skin exudate sampling in 
order to achieve bacteriological examination, regardless of the concerned pyoderma type.  
Any lesion represented by a pustule or furuncle will be scraped in order to perform 
differential diagnosis from demodecosis, dermatophytosis. 
A differential treatment is established depending on the type and depth of the 
infectious process only on the basis of an antibiogram. Treatment consists of topical 
antiseptics or antibiotics and, if necessary, systemic antibiotics. Topical treatment may be 
sufficient in the case of bacterial proliferation on the surface or in some superficial pyoderma. 
(2, 4, 6, 11) Duration of treatment will be determined depending on the type of pyoderma and 
individual response to treatment and may last 2 to 3 or 4 weeks, plus another 1-2 weeks after 
resolution of clinical signs. Systemic antibiotics are used depending on the type of dermatitis 
and its extent. Pyoderma treatment is made difficult by the occurrence of cross-resistance to 
an antibiotic, the chromosomial material and bacterial plasmid DNA beeing responsible for 
this. Knowing that the etiologic agent responsible for the appearance of pyoderma for over 
90% of cases is Staphylococcus pseudintermedius, classes of antibiotics that are particularly 
effective in Gram-positive strains are also used in pyoderma ( table 2). 
Topical therapy: Antiseptic and antibiotic substances in various formulations are 
used: shampoos, lotions, emulsions, creams, ointments, gels, alone or in combination with 
antibiotics. Effective antibiotics that are incorporated in the composition of various 
pharmaceutical products are: bacitracin, neomycin, polymyxin B, gentamicin, fusidic acid 
and muciprocin. Antiseptic shampoos mechanically remove the cellular debris, cellular 
crusts and bacteria, rapidly relieve injuries and speed up the healing process. Shampoos 
with chlorhexidine, benzoyl peroxide, pavidona iodinated, ethyl lactate, piroctone olamine 
are also used. If the main risk factor is the inappropriate use of antibiotics and local 
treatment may prove ineffective, the use of  staph autovaccine is a viable solution,  both in 
prevention of methicillin-resistant strains and in pyoderma control. 
 
CONCLUSIONS 
 
Bacterial dermatitis in dogs have become a current and inconvenient reality especially 
in the past years, these being harder and harder to treat and representing a risk factor for dogs 
and other animal species, and humans as well.  Canine pyoderma represent a challenge 
because of the occurrence of antibiorezistent strains as a consequence to inadequate 
therapeutic management, which consists in under dosed antibiotic treatments, chosen 
inappropriately, without any bacteriological exam or antibiogram done in advance, for a way 
too short period of time or without taking into account the dynamics and evolution of the 
disease. Related to this matter, the non-permitted treatment associations must not be 
forgotten, such as antibiotics combined with glucocorticoids, which bring comfort by 
reducing the swelling and itching sensations, but represent one of the causes for the pyoderma 
relapses in dogs and even for their aggravation in long term usage.  
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Annex 1 
The main clinico-lesional aspects and diferential diagnosis in dog pyoderma 
 
Table 1 
PYODERMA 
TYPE I 
DEFINITION LESIONS TOPOGRAPHY 
DIFFERENTIAL 
DIAGNOSIS 
COMPLEMENTARY EXAMINATIONS 
CYTOLOGICAL 
EXAMINATION 
HISTOPATHOLOGICA
L EXAMINATION 
SUPERFICIAL  PYODERMA      
Intertrigo/ 
Skin Fold 
Pyoderma 
Bacterial colonization of 
the skin folds secondary 
surface (face, lips, vulva, 
mammae, tail) 
erythema, 
exudation, 
erosion, even 
ulceration, 
suppuration 
face, lips, vulva, 
mammae, tail 
Demodicosis 
Candidiasis 
Malassezia 
Contact Dermatitis 
Zinc-responsive 
Dermatosis 
Cutaneous Lupus 
/pemphigus 
Cutaneous Lymphoma 
Bacterial 
colonization, 
seldom, bacterial 
invasion 
Not necessary. 
 
Epidermal hyperplasia, 
Infiltration of superficial 
inflammatory 
Impetigo 
- juvenile 
- adult (Pustular 
Impetigo; 
bullous) 
Small collections of pus 
in the skin 
 
It occurs in adults after 
traumas or after 
Cushing’s disease. 
Nonfollicular 
pustules, 
vesicles/bubbles,  
yellowish crusts 
of varying sizes, 
epidermal 
collarettes, 
alopecia, 
inflammatory 
rashes 
For the impuber 
animal- mostly on the 
abdominal area 
The entire surface of 
the adult’s body; or on 
the neck, thorax, 
abdomen. 
demodicosis 
dermatophytosis 
leishmaniasis 
Cutaneous injuries 
caused by drugs 
B.autoimmune 
(Pemphigus) 
Bacterial invasion Subcorneal pustules filled 
with neutrophils and 
bacteria 
Juvenile 
Folliculitis 
A purulent collection at 
the superficial level of 
the hair follicle. 
Papules, heavily 
erythematous 
pustules centered 
on the hair shaft, 
crusts, epidermal 
collarettes. 
Abdomen, 
thighs 
dermatophytosis 
demodecosis 
several polimorfo-
nuclear  
degenerated 
neutrophils, some 
undergoing 
phagocytosis. 
Infiltration of neutrophils, 
eosinophils and bacteria in 
the follicular ostium. 
Folliculitis at 
dogs with short 
Specific to short-haired 
breeds (boxer, German 
Follicular 
pustules, 
Thorax, abdomen; 
Thighs, rump, the ribs, 
demodecosis 
dermatophytosis 
Bacterial invasion Id. Juvenile Folliculitis 
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hair brac, doberman, German 
dog, pointer, shar-pei) 
collarettes and 
crusts, alopecia; 
“the mothy” fur 
Variable pruritus 
etc. allergic dermatitis 
Secondary 
Folliculitis 
-secondary to some 
purulent or non-purulent 
primary diseases-
relapsing  
Macules, 
papules, pustules, 
epidermal 
collarettes, 
crusts. 
Localized or 
generalized 
demodecosis 
dermatophytosis 
Bacterial invasion Id. Folliculitis 
Bacterial 
Hypersensitivity/ 
Superficial 
pyoderma 
(centrifugal) 
Involves a 
hypersensitivity to 
certain strains of 
staphylococci from the 
skin barrier 
centripetal 
intensely 
erythematous 
lesions: 
follicular 
pustules, 
hemorrhagic 
bubbles 
seborrheic 
plagues bounded 
by epidermal 
collarettes, 
crusts, 
alopecia, pruritus 
Localized or 
generalized 
Pemphigus 
Erythema multiforme 
The cytological 
examination may 
not be clinching. 
The histopathological 
examination shows the 
presence of bacteria in the 
epidermis, with 
neutrophils that appear in 
the dermis. 
 
Acral lick 
dermatitis 
Superficial at first, it can 
become a serious 
bacterial infection 
associated with a 
purulent inflammation of 
the sweat glands 
Erythema 
Erosion 
Often localised on the 
memebers 
 Bacterial 
colonization or 
invasion 
 
Folliculitis / 
furunculosis 
piotraumatica 
 Edematic 
exudative and 
painful plagues, 
associated with 
pustules and 
furuncles 
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DEEP PYODERMA      
Furunculosis of the 
muzzle or chin 
Deep purulent 
gathering on the 
hair follicles.  
It occurs at juvenile 
dogs. 
papules, pustules, 
furuncles, 
sangvino-
purulent exudate, 
crusts 
Dermis and 
hypodermis 
nose or chin 
demodicosis 
Zinc-responsive 
Dermatosis Juvenile 
Cellulitis 
Bacterial invasion  
Secondary 
furunculosis 
Occurs after a 
trauma or after an 
autoimmune 
process 
Pustules, 
furuncles, 
  fistulas, 
ulceration 
purulent exudate, 
Nose and eyelid 
(variable 
consequences), neck, 
interdigital areas, 
pressure points 
(shoulder, anus) 
   
Localised cellulitis The expanding of 
the infectious 
process by the 
conjunction of 
several furuncles 
suppurative 
purulent collection 
ulceration, 
necrosis, 
fistulization and 
bloody pus 
necrosis, 
swelling 
In the pressure points: 
elbow; 
interdigital, plantar and 
palmar 
anus 
perianal abscess 
demodecosis 
Bacterial invasion, 
piogranulomatous 
reaction. 
Germs and 
phagocytosis 
pictures are not 
common. 
It is recommended the 
differential diagnosis 
from: 
 Sterile piogranuloma, 
neoplasia etc. 
Generalized cellulitis: 
piodemodicosis 
 It occurs after 
demodecosis  
 Generalized    
   Other cellulitis They occurs after 
certain immune-
deficiencies 
necrotic lesions     
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